• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AptarGroup Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    11/20/25 4:30:57 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    false 0000896622 0000896622 2025-11-20 2025-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    November 20, 2025

    Date of Report (Date of earliest event reported)

     

     

    AptarGroup, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware
    (State or other jurisdiction
    of incorporation)
      001-11846
    (Commission
    File Number)
      36-3853103
    (IRS Employer
    Identification No.)

     

    265 Exchange Drive, Suite 301, Crystal Lake, Illinois 60014

    (Address of Principal Executive Offices)

     

    Registrant’s telephone number, including area code: (815) 477-0424

     

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

      

    Title of each class   Trading
    symbol(s)
      Name of each exchange
    on which registered
    Common Stock, $0.01 par value   ATR   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company   ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

    Item 1.01.Entry into a Material Definitive Agreement.

     

    Issuance of 4.750% Senior Notes due 2031

     

    On November 20, 2025, AptarGroup, Inc. (the “Company”) completed an underwritten public offering (the “Offering”) of $600 million aggregate principal amount of its 4.750% Senior Notes due 2031 (the “Notes”). The offering of the Notes was made pursuant to the Company’s effective shelf registration statement on Form S-3ASR (File No. 333-276977) and a related prospectus supplement dated November 17, 2025. The Notes were issued under an Indenture, dated as of March 7, 2022 (the “Base Indenture”), as amended and supplemented by a Second Supplemental Indenture, dated as of November 20, 2025 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), each between the Company and U.S. Bank Trust Company, National Association, as trustee.

     

    The Notes mature on March 30, 2031 and bear interest at the rate of 4.750% per annum, payable semi-annually in arrears on March 30 and September 30 of each year, beginning March 30, 2026. The Notes are unsecured obligations of the Company and rank equally in right of payment with all of the Company’s other existing and future senior unsecured indebtedness.

     

    Prior to February 28, 2031 (the “Par Call Date”), the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a “make-whole” redemption price, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after the Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes being redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date.

     

    Upon the occurrence of a “Change of Control Repurchase Event” (as defined in the Second Supplemental Indenture), unless the Company has exercised its right to redeem the Notes, the holders of the Notes may require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of their Notes, plus accrued and unpaid interest, if any, on the Notes repurchased to, but not including, the repurchase date.

     

    The Indenture contains certain covenants that limit the ability of the Company and its restricted subsidiaries to, among other things, incur certain liens securing indebtedness, enter into certain sale and lease-back transactions and enter into certain consolidations or mergers or sales, assignments, transfers, leases, conveyances or other dispositions of all or substantially all of the Company’s assets. The Indenture also provides for customary events of default (subject in certain cases to customary grace periods), which include nonpayment, breach of covenants in the Indenture, a cross-default under certain other indebtedness, and certain events of bankruptcy, insolvency and reorganization. Generally, if an event of default occurs, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding Notes may declare the principal amount of all the outstanding Notes to be due and payable immediately, except that if an event of default arising from certain events of bankruptcy, insolvency or reorganization occurs, the principal amount of all the outstanding Notes will become due and payable without any further action or notice.

     

    The foregoing description of the Indenture, the Second Supplemental Indenture and the Notes is qualified in its entirety by reference to the complete terms and conditions of the Indenture, the Second Supplemental Indenture and the form of Note, which are filed as Exhibits 4.1, 4.2 and 4.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

     

    Item 8.01.Other Events.

     

    In connection with the Offering, on November 17, 2025, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, PNC Capital Markets LLC, SG Americas Securities, LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule 1 to the Underwriting Agreement (collectively, the “Underwriters”), with respect to the offer and sale of the Notes. The Underwriting Agreement includes customary representations, warranties and covenants by the Company. The Underwriting Agreement also provides for customary indemnification by each of the Company and the Underwriters (in the case of the Underwriters, severally and not jointly) against certain liabilities and customary contribution provisions in respect of those liabilities.

     

    The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the complete terms and conditions of the Underwriting Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. In connection with the issuance of the Notes, Sidley Austin LLP provided the Company with the legal opinion attached hereto as Exhibit 5.1.

     

     

     

    Item 9.01.Financial Statements and Exhibits.

     

    (d) Exhibits

     

    1.1 Underwriting Agreement, dated November 17, 2025, among AptarGroup, Inc. and J.P. Morgan Securities LLC, PNC Capital Markets LLC, SG Americas Securities, LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein
       
    4.1 Indenture, dated as of March 7, 2022, between AptarGroup, Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K of AptarGroup, Inc. filed on March 7, 2022)  
       
    4.2 Second Supplemental Indenture, dated as of November 20, 2025, between AptarGroup, Inc. and U.S. Bank Trust Company, National Association, as trustee
       
    4.3 Form of 4.750% Senior Notes due 2031 (included as Exhibit A to the Second Supplemental Indenture filed herewith as Exhibit 4.2)
       
    5.1 Opinion of Sidley Austin LLP dated November 20, 2025
       
    23.1 Consent of Sidley Austin LLP (included in  Exhibit 5.1)
       
    104 Cover Page Interactive Data File, formatted in Inline XBRL

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      APTARGROUP, INC.
       
    By: /s/ Vanessa Kanu
        Vanessa Kanu
        Executive Vice President and Chief Financial Officer
         
    Date: November 20, 2025    

     

     

     

    Get the next $ATR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    1/3/2024$125.00 → $150.00Neutral → Outperform
    Robert W. Baird
    1/20/2022$150.00 → $126.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today announced its participation at the Jefferies Global Healthcare Conference on Wednesday, November 19, 2025. Stephan Tanda, President and CEO, will present at 7:00 a.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available. A live audio webcast and presentation materials will be available in the "Investors" section of the Company's website at www.aptar.com. About Aptar Aptar is a global leader in drug delivery and consumer product dosing, dispensing and protection technol

    11/11/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Third Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030956269/en/Aptar Reports Third Quarter 2025 Results Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% and core sales increased 1% Strong product volume growth

    10/30/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

    Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense - a Bluetooth-enabled sensor - as an innovative connected add-on for pressurized Metered Dose Inhalers (pMDIs), transforming traditional inhalers into smart, data-driven devices for patients and healthcare professionals. Designed for individuals aged 12 and above, HeroTracker® Sense is compatible with several commonly prescribed asthma and chronic obstructive pulmonary disease (COPD) medications, includ

    10/16/25 8:00:00 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hudson Irene Elizabeth claimed ownership of 798 shares (SEC Form 3)

    3 - APTARGROUP, INC. (0000896622) (Issuer)

    11/10/25 2:13:29 PM ET
    $ATR
    Plastic Products
    Industrials

    Segment President Touya Gael sold $340,298 worth of shares (2,500 units at $136.12), decreasing direct ownership by 7% to 31,463 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/12/25 8:12:33 AM ET
    $ATR
    Plastic Products
    Industrials

    Chief Human Resources Officer Vinczeller Shiela sold $161,006 worth of shares (1,167 units at $137.97), decreasing direct ownership by 4% to 25,134 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/8/25 12:50:17 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    KeyBanc Capital Markets initiated coverage on AptarGroup with a new price target

    KeyBanc Capital Markets initiated coverage of AptarGroup with a rating of Overweight and set a new price target of $220.00

    9/4/25 8:59:59 AM ET
    $ATR
    Plastic Products
    Industrials

    Raymond James initiated coverage on AptarGroup with a new price target

    Raymond James initiated coverage of AptarGroup with a rating of Outperform and set a new price target of $200.00

    1/7/25 9:09:40 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    AptarGroup Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    11/20/25 4:30:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 424B5 filed by AptarGroup Inc.

    424B5 - APTARGROUP, INC. (0000896622) (Filer)

    11/19/25 9:10:40 AM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form FWP filed by AptarGroup Inc.

    FWP - APTARGROUP, INC. (0000896622) (Subject)

    11/17/25 4:47:35 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Julie Xing to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

    3/1/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Third Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030956269/en/Aptar Reports Third Quarter 2025 Results Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% and core sales increased 1% Strong product volume growth

    10/30/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

    Following an increase of almost 10% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025. Stephan B. Tanda, Aptar President and CEO, commented, "Given the strength of our business outlook, the sustained long-term growth we anticipate from our Pharma segment, and our continued strong performance across all key financial metrics, the Board of Dir

    9/8/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Second Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731446602/en/Aptar Reports Second Quarter 2025 Results Second Quarter 2025 Highlights (compared to the prior year quarter) Reported sales increased 6% and core sales increased 3% Reported net income increased 24% to $112 million and adjusted EBITDA increased 13% from the prior year to $218 million Rep

    7/31/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials